Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Plos One|May 1, 2008
Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patientsKaren Yao, Susan Gagnon, Nahid Akhyani, et al.Obesity Research|November 14, 2002
Two measures of health-related quality of life in morbid obesityMartina De Zwaan, James E Mitchell, L Michael Howell, et al.Frontiers in Immunology|April 19, 2021
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk EstimatesScott Christley, Jared Ostmeyer, Lisa Quirk, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 5, 2014
Single dose of glycoengineered anti-CD19 antibody (MEDI551) disrupts experimental autoimmune encephalomyelitis by inhibiting pathogenic adaptive immune responses in the bone marrow and spinal cord while preserving peripheral regulatory mechanismsDing Chen, Monica Blazek, Sara Ireland, et al.Vaccine|July 13, 2025
SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient populationBenjamin M Greenberg, John D Minna, David E Gerber, et al.JAMA Neurology|March 26, 2014
JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumabElliot M Frohman, Maria Chiara Monaco, Gina Remington, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2021
Molecular Level Characterization of Circulating Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum DisorderJie Li, Sam A Bazzi, Florian Schmitz, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2023
VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor EncephalitisNancy Monson, Chad Smith, Hannah Greenberg, et al.Frontiers in Neuroscience|September 19, 2012
A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tractCarrie B Wiese, Sara Ireland, Nicole L Fleming, et al.European Journal of Immunology|September 3, 2010
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoproteinChristopher T Harp, Sara Ireland, Laurie S Davis, et al.Pageof 3